Seroprevalences of hepatitis B and C viruses and Helicobacter pylori infection in a small, isolated population at high risk of gastric and liver cancer

International Journal of Cancer

Volumn 71, Issue 5, 1997, Pages 776-779

  Chen, Shu Yuan ^a   Liu, Tzeng Ying ^b   Chen, Meei Jin ^b   Lin, Jaw Town ^c   Sheu, Jin Chuan ^c   Chen, Chien Jen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b Health Bureau of Lienkiang County   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; HELICOBACTER PYLORI; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROPREVALENCE; STOMACH CANCER; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HELICOBACTER PYLORI; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; RISK FACTORS; STOMACH NEOPLASMS; TAIWAN;

EID: 0030962986     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970529)71:5<776::AID-IJC14>3.0.CO;2-6     Document Type: Article

References (35)

1. BRESLOW, N.E. and DAY, N.E., Statistical methods in cancer research. Vol. II, The design and analysis of cohort studies, pp. 69-70, World Health Organization, Geneva (1987).
2. CHANG, C.C., YU, M.W., LU, C.F., YANG, C.S. and CHEN, C.J., A nested case-control study on association between hepatitis C virus antibodies and primary liver cancer in a cohort of 9,775 men in Taiwan. J. med. Virol., 43, 276-280 (1994).
3. CHEN, C.J., YU, M.W., LIAW, Y.F., WANG, L.W., CHIAMPRASERT, S., MATIN, F., HIRVONEN, A., BELL, D.A. and SANTELLA, R.M., Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Amer. J. hum. Genet., 59, 128-134 (1996a).
4. CHEN, C.J., WANG, L.Y., LU, S.N., WU, M.H., YOU, S.L., ZHANG, Y.J., WANG, L.W. and SANTELLA, R.M., Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology, 24, 38-42 (1996b).
5. CHEN, C.J. and 14 OTHERS, Community-based hepatocellular carcinoma screening in seven townships in Taiwan. J. Formos. med. Ass., 94, S94-102 (1995).
6. CHEN, C.J., YU, M.W., WANG, C.J., HUANG, H.Y. and LIN, W.C., Multiple risk factors of hepatocellular carcinoma: a cohort study of 13,737 male adults in Taiwan. J. Gastroenterol. Hepatol., 8, s83-87 (1993).
7. CHEN, C.J., LIANG, K.Y., CHANG, A.S., CHANG, Y.C., LU, S.N., LIAW, Y.F., CHANG, W.Y., SHEEN, M.C. and LIN, T.M., Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology, 13, 398-406 (1991).
8. DEPARTMENT OF HEALTH, EXECUTIVE YUAN, REPUBLIC OF CHINA, Annual report of cancer registration, 1991, p. 3, Department of Health, Executive Yuan, Taipei (1995).
9. EUROGAST STUDY GROUP, An international association between Helicobacter pylori infection and gastric cancer. Lancet, 341, 1359-1362 (1993).
10. FORMAN, D., MOLLER, H. and COLEMAN, M., International association between Helicobacter pylori and gastric cancer: authors' reply. Lancet, 342, 120-121 (1993).
11. FORMAN, D., NEWELL, D.G., FULLERTON, F., YARNELL, J.W.G., STAGEY, A.R., WALD, N. and SITAS, F., Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Brit. med. J., 302, 1302-1305 (1991).
12. FORMAN, D., SITAS, F., NEWELL, D.G., STAGEY, A.R., BOREHAM, J., PETO, R., CAMPBELL, T.C., LI, J. and CHEN, J., Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int. J. Cancer, 46, 608-611 (1990).
13. GIESECKE, J.,International association between Helicobacter pylori and gastric cancer. Lancet, 342, 120 (1993).
14. HATCH, M.C., CHEN, C.J., LEVIN, B., JI, B.T., YANG, G.Y., HSU, S.W., WANG, L.W., HSIEH, L.L. and SANTELLA, R.M., Urinary aflatoxin levels, hepatitis-B virus infection and hepatocellular carcinoma in Taiwan. Int. J. Cancer, 54, 931-934 (1993).
15. HOLCOMBE, C., Helicobacter pylori: the African enigma. Gut. 33, 429-431 (1992).
16. HUANG, Y.C., TSAI, S.F., LEE, S.S., HSU, K.H., YOU, S.L., LIN, T.M. and CHEN, C.J., Epidemiologic characteristics of malignant neoplasms in Taiwan: III. Stomach cancer. J. nat. publ. Hlth Ass. (ROC), 8, 176-188 (1988).
17. LEE, C.S., SUNG, J.L., HWANG, L.Y. SHEU, J.C., CHEN, D.S., LIN, T.Y. and BEASLEY, R.P. Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma. Surgery, 99, 481-490 (1986).
18. LEE, H.H., WU, H.Y. CHUANG, Y.C., CHANG, A.S., CHAO, H.H., CHEN, K.Y., CHEN, H.K., LAI, G.M., HUANG, H.H. and CHEN, C.J., Epidemiologic characteristics and multiple risk factors of stomach cancer in Taiwan. Anticancer Res., 10, 875-882 (1990).
19. LIN, J.T., WANG, L.Y. WANG, J.T., WANG, T.H. and CHEN, C.J., Ecological study of association between Helicobacter pylori infection and gastric cancer in Taiwan. Digest. Dis. Sci., 40, 385-388 (1995a).
20. LIN, J.T., WANG, L. Y. WANG, J.T., WANG, T.H., YANG, C.S. and CHEN, C.J., A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9.775 men in Taiwan. Anticancer Res., 15, 603-606 (1995b).
21. LU, J.N. and CHEN, C.J., Prevalence of hepatitis B surface antigen carrier status among residents in the endemic area of chronic arsenicism in Taiwan. Anticancer Res., 11, 229-234 (1991).
22. MARSHALL, B.J., Unidentified curved bacillus on gastric epithelium in active chronic gastritis. Lancet, 1, 1273-1275 (1983).
23. NOMURA, A., STEMMERMANN, G.N., CHYOU, P-H., KATO, I., PEREZ-PEREZ, G.I. and BLASER, M.J., Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. New Engl. J. Med., 325, 1132-1136 (1991).
24. PALLI, D. and 13 OTHERS. Helicobacter pylori antibodies in areas of Italy at varying sastric cancer risk. Cancer Epidemiol. Biomarkers Prev., 2, 37-40 (1993).
25. PARKIN, D.M., PISANL P. and FERLAY, J., Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54, 594-606 (1993).
26. PARSONNET, J., FRIEDMAN, G.D., VANDERSTEEN, D.P., CHANG, Y., VOGELMAN, J.H., ORENTREICH, N. and SIBLEY, R.K., Helicobacter pylori infection and the risk of gastric carcinoma. New Engl. J. Med., 325, 1127-1131 (1991).
27. SIERRA, R., MUÑOZ, N., PEÑA, A.S., BIEMOND, I., VAN DUIJN, W., LAMERS, C.B.H.W., TEUCHMANN, S., HERNANDEZ, S. and CORREA, P., Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer. Cancer Epidemiol. Biomarkers Prev., 1, 449-454 (1992).
28. WANG, L.Y., CHENG, Y.W., CHOU, S.J., HSIEH, L.L. and CHEN, C.J., Secular trend and geographical variation in hepatitis A infection and hepatitis B carrier rate among adolescents in Taiwan: an island-wide survey. J. med. Virol., 39, 1-5 (1993).
29. WANG, L.Y. and 13 OTHERS, Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int. J. Cancer, 67, 620-625 (1996).
30. WEBB, P.M., YU, M.C., FORMAN, D., HENDERSON, B.E., NEWELL, D.G., YUAN, J.M., GAO, Y.T. and ROSS, R.K., An apparent lack of association between Helicobacier pylori infection and risk of gastric cancer in China. Int. J. Cancer, 67, 603-607 (1996).
31. WORLD HEALTH ORGANIZATION, International classification of disease: manual of the international statistical classification of diseases, injuries, and causes of death, 1975 revision. Vol. 1, World Health Organization, Geneva (1977).
32. WU, M.S., LIN, J.T., LEE, W.J., YU, S.C. and WANG, T.H., Gastric cancer in Taiwan. J. Formos. med. Ass., 93, S77-89 (1994).
33. YU, M.W., GLADEK-YARBOROUGH, A., CHIAMPRASERT, S., SANTELLA, R.M., LIAW, Y.F. and CHEN, C.J., Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology. 109, 1266-1273 (1995a).
34. YU, M.W., HSIEH, H.H., PAN, W.H., YANG, C.S. and CHEN, C.J., Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma. Cancer Res., 55, 1301-1305 (1995b).
35. YU, M.W., YOU, S.L., CHANG, A.S., LU, S.N., LIAW, Y.F. and CHEN, C.J., Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res., 51, 5621-5625 (1991).